Cargando…
Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based study
BACKGROUND: A reporting association of risperidone with pituitary tumors has been observed. Because such tumors are highly prevalent, there may be other reasons why they were revealed in association with risperidone treatment. We assessed two potential explanations: disproportionately more prolactin...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649125/ https://www.ncbi.nlm.nih.gov/pubmed/19210771 http://dx.doi.org/10.1186/1744-859X-8-5 |